|
|
Post by lakers on Dec 21, 2015 15:10:12 GMT -5
1. Sanofi partnership remains STRONG, going full tilt in 1Q16. I unequivocally believe the death of the partnership has been greatly exaggerated. You can stop doubting it now. For non-believers, you can write off for tax now if it makes you sleep better. But if you are still in, absolutely don't lose sleep over it.
2. Pain mgmt partnership being guided actively by CMO
3. Questions on cash on balance sheet will be addressed in 4Q15 Feb ER CC(had a typo).
4. New CEO most likely TBA 1Q16.
5. PAH: Working on selecting an optimal, commercially viable API
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 21, 2015 15:19:59 GMT -5
1. Sanofi partnership remains STRONG, going full tilt in 1Q16. I unequivocally believe the death of the partnership has been greatly exaggerated. You can stop doubting it now. For non-believers, you can write off for tax now if it makes you sleep better. But if you are still in, absolutely don't lose sleep over it. 2. Pain mgmt partnership being guided actively by CMO 3. Questions on cash on balance sheet will be addressed in 1Q16 May ER CC. Pain mgmt partnership being guided actively by CMO... We now need execution and past the stage of guidance... need a partnership signed with upfront $$$ that will keep the ship afloat |
|
|
|
Post by bearcatmax on Dec 21, 2015 15:21:18 GMT -5
Why would they not answer cash questions on Q4 CC?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 21, 2015 15:22:15 GMT -5
Why would they not answer cash questions on Q4 CC? blackout period lol.. < end sarcasm > |
|
|
|
Post by vissertrades on Dec 21, 2015 15:24:55 GMT -5
Status quo, drip, drip, drip... This is just like being lost in the desert and hallucinating over mirage after mirage. Water, we need water! Wait, I see some camel shit, but I'm no bear grylls, Just shoot me please!
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 21, 2015 15:36:28 GMT -5
Why would they not answer cash questions on Q4 CC? blackout period lol.. < end sarcasm > Matt moonlights as director of NSA or at least behaves like he does |
|
|
|
Post by bearcatmax on Dec 21, 2015 15:38:45 GMT -5
Thanks for update Lakers. Appreciate your posts.
|
|
|
|
Post by peppy on Dec 21, 2015 15:45:07 GMT -5
1. Sanofi partnership remains STRONG, going full tilt in 1Q16. I unequivocally believe the death of the partnership has been greatly exaggerated. You can stop doubting it now. For non-believers, you can write off for tax now if it makes you sleep better. But if you are still in, absolutely don't lose sleep over it. 2. Pain mgmt partnership being guided actively by CMO 3. Questions on cash on balance sheet will be addressed in 4Q15 Feb ER CC(had a typo). 4. New CEO most likely TBA 1Q16. 5. PAH: Working on selecting an optimal, commercially viable API Someone in the know told you this? |
|
|
|
Post by mssciguy on Dec 21, 2015 15:51:47 GMT -5
peppy if he told you that he'd have to .... ;-)
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 21, 2015 15:52:01 GMT -5
1. Sanofi partnership remains STRONG, going full tilt in 1Q16. I unequivocally believe the death of the partnership has been greatly exaggerated. You can stop doubting it now. For non-believers, you can write off for tax now if it makes you sleep better. But if you are still in, absolutely don't lose sleep over it. 2. Pain mgmt partnership being guided actively by CMO 3. Questions on cash on balance sheet will be addressed in 4Q15 Feb ER CC(had a typo). 4. New CEO most likely TBA 1Q16. 5. PAH: Working on selecting an optimal, commercially viable API 5. PAH: Working on selecting an optimal, commercially viable API How long do they take to select an API.. Write pros and cons on a board - give weight age to each and go ahead... Damn.. I thought they hired a firm and spent $$$ to select an API.. why select again? They will keep selecting 4 ever.. |
|
|
|
Post by vissertrades on Dec 21, 2015 15:54:01 GMT -5
Why not a letter from Mannkind to SHAREHOLDERS letting US know what the HELL is going on! There's a NOVEL idea...
|
|
|
|
Post by mssciguy on Dec 21, 2015 15:56:20 GMT -5
1. Sanofi partnership remains STRONG, going full tilt in 1Q16. I unequivocally believe the death of the partnership has been greatly exaggerated. You can stop doubting it now. For non-believers, you can write off for tax now if it makes you sleep better. But if you are still in, absolutely don't lose sleep over it. 2. Pain mgmt partnership being guided actively by CMO 3. Questions on cash on balance sheet will be addressed in 4Q15 Feb ER CC(had a typo). 4. New CEO most likely TBA 1Q16. 5. PAH: Working on selecting an optimal, commercially viable API pardon my bold, but here goes Pain mgmt partnership being guided actively by CMO
This year has broken ALL RECORDS for drug overdose deaths due to opiates, both prescription (eg oxycodone) and heroin.
Pain management by non-addictive peptides might be of even greater benefit to mankind in the US than Afrezza at this time. Seriously. But don't let Purdue pharma know about this, they'll dredge up a Martin Shrkeli to shoot holes in the NDA. A lot of seriously addicted people out there and these days it can be anyone. |
|
|
|
Post by jay1ajay1a on Dec 21, 2015 16:17:44 GMT -5
Lakers, I also feel that Sanofi will be around and is not going anywhere. The disappointment (one of them) I have right now is the last CC they stated we would have a partnership announced by the end of the year, not much time left for that to happen.
|
|
|
|
Post by bradleysbest on Dec 21, 2015 16:20:56 GMT -5
Back in June Matt sounded so confident regarding TS & soon to be announced deals. Now not so much.... Hopefully the delay is just a bump in the road. At least that's my hope.....
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 21, 2015 16:24:22 GMT -5
1. Sanofi partnership remains STRONG, going full tilt in 1Q16. I unequivocally believe the death of the partnership has been greatly exaggerated. You can stop doubting it now. For non-believers, you can write off for tax now if it makes you sleep better. But if you are still in, absolutely don't lose sleep over it. 2. Pain mgmt partnership being guided actively by CMO 3. Questions on cash on balance sheet will be addressed in 4Q15 Feb ER CC(had a typo). 4. New CEO most likely TBA 1Q16. 5. PAH: Working on selecting an optimal, commercially viable API pardon my bold, but here goes Pain mgmt partnership being guided actively by CMO
This year has broken ALL RECORDS for drug overdose deaths due to opiates, both prescription (eg oxycodone) and heroin.
Pain management by non-addictive peptides might be of even greater benefit to mankind in the US than Afrezza at this time. Seriously. But don't let Purdue pharma know about this, they'll dredge up a Martin Shrkeli to shoot holes in the NDA. A lot of seriously addicted people out there and these days it can be anyone.Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014 Early Release December 18, 2015 / 64(Early Release);1-5 |
|
